Compare CVS Health Corp (CVS) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Wayfair Inc — how do they compare? CVS Health Corp trades at $104.32 (market cap $135.48B), while Wayfair Inc trades at $88.76 (market cap $11.71B). The key difference: CVS Health Corp is far larger — about 11.6× Wayfair Inc's market cap, and CVS Health Corp pays a 2.51% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| CVS | W | |
|---|---|---|
Market Cap | $135.48B | $11.71B |
Sector | Health | Consumer Cyclical |
52-Week High | $106.18 | $119.05 |
52-Week Low | $58.75 | $53.37 |
Enterprise Value | $202.02B | $14.29B |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Wayfair (W) trades at $86.37, down 3.21% today, with a bearish technical signal but strong analyst support. Recent earnings show mixed results, beating estimates in Q3 and Q4 2025 but missing in Q1 2026. The company maintains revenue growth but operates at a net loss, with a negative net income margin of -2.41%. Positive sentiment is driven by expansion into brick-and-mortar stores and AI integration, as highlighted by Bloomberg on July 8, 2026.
The outlook is cautiously optimistic due to a 51.78% buy rating from analysts and a consensus price target of $92.64, offering potential upside. However, risks include persistent unprofitability, high debt-to-asset ratio of 95.11%, and competitive e-commerce pressures. Investors should weigh growth initiatives against financial sustainability amid macroeconomic challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
